BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22690657)

  • 1. Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes.
    Pruthi J; Mehra NK; Jain NK
    J Drug Target; 2012 Aug; 20(7):593-604. PubMed ID: 22690657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting.
    Nimje N; Agarwal A; Saraogi GK; Lariya N; Rai G; Agrawal H; Agrawal GP
    J Drug Target; 2009 Dec; 17(10):777-87. PubMed ID: 19938949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface-engineered dendrimeric nanoconjugates for macrophage-targeted delivery of amphotericin B: formulation development and in vitro and in vivo evaluation.
    Jain K; Verma AK; Mishra PR; Jain NK
    Antimicrob Agents Chemother; 2015 May; 59(5):2479-87. PubMed ID: 25645852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
    Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
    J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis.
    Rathore A; Jain A; Gulbake A; Shilpi S; Khare P; Jain A; Jain SK
    J Liposome Res; 2011 Dec; 21(4):333-40. PubMed ID: 21612342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
    Falamarzian A; Lavasanifar A
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
    Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
    J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles.
    Nahar M; Jain NK
    Pharm Res; 2009 Dec; 26(12):2588-98. PubMed ID: 19842021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
    Jain S; Valvi PU; Swarnakar NK; Thanki K
    Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface structured liposomes for site specific delivery of an antiviral agent-indinavir.
    Dubey V; Nahar M; Mishra D; Mishra P; Jain NK
    J Drug Target; 2011 May; 19(4):258-69. PubMed ID: 20604740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
    Jain SK; Gupta Y; Jain A; Saxena AR; Khare P; Jain A
    Nanomedicine; 2008 Mar; 4(1):41-8. PubMed ID: 18207463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysinated Multiwalled Carbon Nanotubes with Carbohydrate Ligands as an Effective Nanocarrier for Targeted Doxorubicin Delivery to Breast Cancer Cells.
    Thakur CK; Neupane R; Karthikeyan C; Ashby CR; Babu RJ; Boddu SHS; Tiwari AK; Moorthy NSHN
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
    Chaubey P; Patel RR; Mishra B
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug targeting to arthritic region via folic acid appended surface-engineered multi-walled carbon nanotubes.
    Kayat J; Mehra NK; Gajbhiye V; Jain NK
    J Drug Target; 2016; 24(4):318-27. PubMed ID: 26289435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of amphotericin B loaded polymersomes based on (PEG)(3)-PLA co-polymers: Factors affecting size and in vitro evaluation.
    Jain JP; Kumar N
    Eur J Pharm Sci; 2010 Aug; 40(5):456-65. PubMed ID: 20580669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.
    Garg M; Asthana A; Agashe HB; Agrawal GP; Jain NK
    J Pharm Pharmacol; 2006 May; 58(5):605-16. PubMed ID: 16640829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers.
    Gajbhiye V; Ganesh N; Barve J; Jain NK
    Eur J Pharm Sci; 2013 Mar; 48(4-5):668-79. PubMed ID: 23298577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers.
    Kumar PV; Asthana A; Dutta T; Jain NK
    J Drug Target; 2006 Sep; 14(8):546-56. PubMed ID: 17050121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting.
    Gupta S; Vyas SP
    J Drug Target; 2007 Apr; 15(3):206-17. PubMed ID: 17454358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.